Shares of Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) were up 2.2% during mid-day trading on Tuesday . The company traded as high as $6.00 and last traded at $5.99. Approximately 594,425 shares were traded during trading, an increase of 8% from the average daily volume of 551,962 shares. The stock had previously closed at $5.86.
Cybin Trading Up 2.2%
The stock has a 50 day moving average of $6.90 and a 200-day moving average of $7.17. The stock has a market capitalization of $890.10 million and a P/E ratio of -24.96.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Read More
- Five stocks we like better than Cybin
- The How And Why of Investing in Oil Stocks
- PayPal Stock: Why Wall Street May Be Undervaluing This Giant
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Why Vertical Aerospace Could Lead the eVTOL Market by 2028
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Is Draganfly’s Army Partnership a Game-Changer for Investors?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
